Skip to main content
. Author manuscript; available in PMC: 2021 Feb 6.
Published in final edited form as: Burns. 2017 Oct 28;43(8):1673–1681. doi: 10.1016/j.burns.2017.10.001

Table 2 –

Operative time cohort demographics and outcomes.

All (N=983) <3h (N=448) 3–3.9h (N=272) 4–4.9h (N=175) ≥5h (N=88) P-value
Demographics
Female, %  30  31  30  31  26 0.8271
Age, mean (std)  48 (18)  47 (18)  47 (18)  47 (17)  49 (19) 0.9063
TBSA, median (IQR)  14 (3–30)  5 (3–10)  13 (7–25)  18 (10–28)  19 (13–30) <0.001*
Inhalation injury, %  14  6  21  19  23 <0.0001*
Smoking history, %  45  41  50  42  53 0.0308*
Drug use, %  15  15  17  14  13 0.6738
Alcohol use, %  43  41  48  45  36 0.1584
Co-morbidity count, median  2 (1–3)  1.0 (0–1.0)  0.0 (0.0–1.0)  0.0 (0.0–1.0)  0.0 (0.0–1.5) 0.9039
Post-operative outcomes
Death, %  4  1  8  6  9 <0.0001*
Pulmonary embolus, %  1  1  2  0  3 0.0137*
Sepsis, %  11  2  18  23  18 <0.0001*
ARDS, %  5  2  9  9  15 <0.0001*
MODS, %  5  1  7  10  9 <0.0001*
Pneumonia, %  18  6  28  34  33 <0.0001*
Urinary tract infection, %  16  8  22  25  22 <0.0001*
Wound infection, %  18  14  27  22  25 0.0001*
*

Significance is <0.05.